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Elevated blood pressure (BP) is a growing burden worldwide, leading to over 10 million deaths each year. May
Measurement Month (MMM) is a global initiative organized by the International Society of Hypertension aimed at
raising awareness of high BP and to act as a temporary solution to the lack of screening programs worldwide. A
similar approach has been used in Italy since 2012, showing inadequate awareness of the consequences of hyper-
tension, a generally increased cardiovascular risk and unsatisfactory BP control in 36% of interviewed individuals.
An opportunistic cross-sectional survey of volunteers aged 18 was carried out in May 2017, during the joint MMM
and World Hypertension Day events. Blood pressure measurement, the deﬁnition of hypertension and statistical
analysis followed the standard MMM protocol. Screenings were conducted both in cities and villages, indoor and
outdoor, by health personnel. Eighty-ﬁve sites, involving approximately 300 investigators, took part in MMM17/
World Hypertension Day in Italy, screening 10 076 individuals during a month-long period. After multiple imputa-
tion, 3099 participants were found (30.8%) to have high BP levels. This was the biggest opportunistic BP screening
in a single time-point ever reported in Italy. A signiﬁcant proportion of individuals had high BP, although it was not
possible to differentiate between known treated hypertensive patients with inadequate BP control and as yet
undiagnosed hypertensive individuals. Opportunistic screening can reach a signiﬁcant number of individuals, being
a powerful tool for raising awareness and carrying out BP screening.
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Introduction
Atherosclerosis-related cardiovascular diseases (CVD) rep-
resent a burden on western countries’ health systems. In
spite of the many efforts towards primary and secondary
prevention, CVDs prevalence is constantly increasing,
partly because of unhealthy lifestyle and partly because of
the improvements of acute coronary syndromes therapy,
which has led to a decrease in the mortality due to coro-
nary events at the cost of a growing number of individuals
who live with a damaged heart.1 At the moment, CVDs re-
main the main cause of premature death in Europe and one
of the most important causes of disability.
The scientific community and the World Health
Organisation (WHO) jointly identify primary prevention,
and specifically the correction of modifiable risk factors, as
the key step towards the goal of CVDs reduction.2,3 Among
all, arterial hypertension, known as the “silent killer”, is
themost important independent risk factor for CVDs.4
Reported HT prevalence in Italy ranges from 55% to 59%
of the whole population >18years of age,5 with a worri-
some rate of 11% in the 18–35 years age range.6 Moreover,
data collected in Italy during the 2014 World Hypertension
Day, promoted by the International Society of
Hypertension, the World Hypertension League and the
Italian Society of Hypertension, showed that individuals
are aware of healthy life habits useful to reduce blood
pressure (BP) but are not equally aware of the risks linked
with hypertension.7 As a consequence, they may lack moti-
vation in following healthy lifestyle changes and medical
prescription. Thus, we believe that large-scale health cam-
paigns ‘in the field’ may play a pivotal role not only in
screening and assessment of the BP situation at a given
time point, but also in educating people regarding the risks
and consequences connected to high BP, thus improving ad-
herence to lifestylemodification andmedical prescription.
By being part of the May Measurement Month (MMM17)
project organized by the International Society of
Hypertension, we were able to increase the number of
days of data collection, thus reaching more people and in-
volvingmore health personnel than ever before.
Methods
MMM17 activities in Italy were coordinated by G.P. with the
help of C.T. and with the support of the Italian Society of
Hypertension. Informed consent was obtained for each par-
ticipant onsite. No personal information was requested, as
all forms were anonymous.
During the month of May 2017, 85 sites in Italy operated
for a different number of days (from 1 to 10days depending
on the site), interviewing andmeasuring the BPof individu-
als aged 18 and over who decided to stop by. A total esti-
mated number of 300 volunteers were involved in the
campaign.
Blood pressure measuring stations were available inside
hospitals and at crossroads, with the logistical support of
the Italian Red Cross, both in cities and villages. Also,
thanks to the support of Italian Navy, BP measurements
were available for people visiting the sail training ship
‘Amerigo Vespucci’ in a number of ports where this histori-
cal and world-famous ship made scheduled calls along the
peninsula. The initiative was also supported by national
government agencies, with many politicians agreeing to
take part in this initiative and have their BPmeasured.
All the staff had a certain degree of training in health
care and received specific training on BP measurements.
Either doctors, nurses, paramedics and medical students
performed the BP recordings and administered an ad hoc
created questionnaire. Additionally, outdoor measure-
ments were performed in gazebos, in order to keep the am-
bient temperature controlled and even, and to allow
seated rest before the measurement. All selected devices
had been validated accordingly to the ESH-IP approach and
BP measurements were performed according to the
European Society of Hypertension/European Society of
Cardiology (ESH/ESC) 2013 guidelines. Briefly, three con-
secutive measurements were collected in the sitting posi-
tion, at rest with back and arm supported, after a 5-min
rest. Hypertension was defined as BP 140/90mmHg and/
or taking antihypertensivemedication.
The study was bottom funded, i.e. each centre which de-
cided to take part in the activity printed its own question-
naires and BP forms and then sent the hard copies to the
core lab for data entry. Data were checked and cleaned lo-
cally by E.M. and A.F. and analysed by the MMM team
according to the standard analysis plan.
Results
A total of 10 076 people were screened during the month of
May 2017.
Of these 10 076 individuals, 4959 (49.2%) were females.
Mean age (6 standard deviation) was 53.7 years (617.9
years). Blood pressure results across the three readings are
shown in Table 1, showing a decline from the first, to sec-
ond, to third readings.
For BP analysis, the mean of the second and third meas-
urements were used (available in 10 014 individuals). The
mean systolic BP was 129.7mmHg, and mean diastolic BP
was 78.1mmHg. After imputation, a mean reading was
available for 10 075 individuals. The total number with hy-
pertension was 3099, representing 30.8% of the total.
Discussion
There is great awareness in the Italian scientific commu-
nity and among officers of the Italian Health Care System
about the hypertension problem, with the Italian Society
of Hypertension being very active in educational cam-
paigns and large-scale data collection. During the last
few years, a yearly event focused on subjects’ education
on hypertension among the Italian population and on BP
measurements was organized, gaining progressively
more and more attention and involving an increasing
number of people.6–8
The present cross-sectional survey provides a contempo-
rary update on BP values collected nation-wide from a re-
markable sample of the Italian population. As described, a
proportion of 30.8% of the screened individuals were found
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to be hypertensive, a percentage slightly less than the one
reported by Torlasco et al.8 in a similar previous campaign
(36% among a sample of 8657 individuals, focusing on data
collected in year 2015 in a similar fashion). Similarly, the
mean BP values of the current sample are similar to those
that were reported by Tocci et al.5 from 2004 to 2010 (131/
796 19/11mmHg) and by Torlasco et al.8 in 2015 (133/
806 18/10mmHg).
Unfortunately, the available data do not allow differenti-
ation between known treated hypertensive patients with
inadequate BP control and yet undiagnosed hypertensive
people. Moreover, the current lack of recommended BP
thresholds and targets for BP values obtained in the frame
of this ‘street epidemiology’ campaign, based on such a pe-
culiar type of out-of-office BP measurement technique,
makes it unclear how to properly interpret the data col-
lected. Nevertheless, based on extrapolation from previ-
ous surveys, we believe that these results highlight a still
unsatisfactory BP control in a large sample of the Italian
population, which needs to be adequately dealt with, al-
though a trend towards an improvement over the years
seems to become apparent.
Joining the MMM Campaign, we have been able to in-
terview the largest number of people approached in a
single time point so far, also measuring their BP in a care-
fully standardized manner. The results we have obtained
support the belief that population-based campaigns pro-
vide a significant contribution to spread awareness,
stimulate curiosity and collect data in large numbers of
individuals over a relatively short time window.
Moreover, the results obtained in this and in previous
campaigns demonstrate how this kind of population
screening might be useful to reach specific subgroups in
a population, e.g. the young adults, which are usually
healthy and rarely feel the need to engage in primary
prevention focusing on risk factors and subclinical condi-
tions, also because of their limited interactions with
general practitioners resulting, among other problems,
in having BP measured very rarely.
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